The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $352.
Acuity Inc. AYI
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Acuity Inc.
read at $333.72
Acuity Inc. holds its Markup at $333.72.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 13 days |
| Price | $333.72 |
| Valuation | 22.17 trailing · 15.38 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.28 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 1.60% |
| Profit margin | 10.25% |
| Debt to equity | 28.21 |
| Analyst consensus | Buy · 7 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Everyday Lights But Little Room to Grow
Think of the lights that flick on in offices, factories and car parks every morning. Acuity supplies the fixtures and controls that make it happen, yet the business is expanding revenue at just 2% a year with a 10% profit margin. At 15.4 times forward earnings the shares look reasonable on paper and the ethical screen is clear, but the combination of modest returns on equity at 17% and an unknown competitive edge leaves no real opportunity.
We therefore pass. The analyst target of 390 dollars sits only modestly above the current price, and our own fair value of 412 dollars does not change the underlying picture of a slow-moving industrial supplier.
The main risk is that any slowdown in construction or refurbishment spending quickly hits volumes, and the low growth rate offers little buffer. Analysis, not advice.
| Forward P/E | 15.4x expensive even after accounting for its growth |
| Trailing P/E | 22.2x a premium valuation |
| Revenue growth | 1.6% slow but positive growth |
| Profit margin | 10.3% thin but positive margins |
| Return on equity | 17.4% a solid return on shareholder capital |
| Debt to equity | 0.28 minimal debt — a conservative balance sheet |
| Current ratio | 2.05 comfortably covers its short-term bills |
| Beta | 1.28 moves a little more than the market |
| Market cap | $10.0B |
| Employees | 13,800 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in AYI's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
AYI trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (8 analysts) rates it buy, with a mean price target of $352.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $289.62 | -3.0% | · | $970 | -3.0% |
| 2 months | $278.25 | +1.0% | $0.20 | $1,011 | +1.1% |
| 3 months | $257.61 | +9.1% | $0.20 | $1,092 | +9.2% |
| 6 months | $374.13 | -24.9% | $0.40 | $752 | -24.8% |
| 1 year | $275.76 | +1.9% | $0.74 | $1,022 | +2.2% |
| 2 years | $253.15 | +11.0% | $1.38 | $1,115 | +11.5% |
| 3 years | $158.66 | +77.1% | $1.94 | $1,783 | +78.3% |
| 5 years | $185.72 | +51.3% | $2.98 | $1,529 | +52.9% |
Historical returns from market close data. Past performance does not guarantee future results.